Table 2 Observed and expected cancers among the HIV-infected patients as compared to the general population
Observational-time | 1986-2009 | ||
|---|---|---|---|
Cancer type or site (ICD-10) | Observed (n) | Expected (n) | SIR (95% CI) |
AIDS-defining-cancer | |||
Kaposi’s sarcoma (C46) | 287 | 1.7 | 168.5 (149.6-189.2) |
Cervix Uteri (C53)^ | 41 | 2.3 | 17.9 (12.8-24.2) |
Non-Hodgkin lymphoma (C82-5, C96) | 313 | 12.8 | 24.5 (21.8-27.3) |
Non-AIDS-defining-cancer | |||
Tongue and lingual tonsil (C01-C02) | 5 | 0.2 | 22.1 (7.1-51.5) |
Stomach (C16) | 9 | 6.5 | 1.4 (0.6-2.6) |
Colon (C18) | 32 | 14.2 | 2.2 (1.5-3.2) |
Rectum-Anus (C19-21) | 24 | 7.7 | 3.1 (2.0-4.7) |
Liver, primary (C22) | 61 | 5.8 | 10.6 (8.1-13.6) |
Larynx (C32) | 9 | 3.3 | 2.8 (1.3-5.3) |
Lung, bronchus and trachea (C33-34) | 29 | 19.5 | 1.5 (1.0-2.1) |
Melanoma (C43) | 14 | 12.9 | 1.1 (0.6-1.8) |
Breast (C50) | 32 | 24.7 | 1.3 (0.9-1.8) |
Vagina and vulva (C51-52, 57) | 5 | 0.2 | 22.1 (7.1-51.5) |
Penis (C60) | 8 | 0.3 | 28.0 (12.1-55.2) |
Prostate (C61) | 8 | 16.2 | 0.5 (0.3-1.0) |
Testis (C62) | 19 | 7.9 | 2.4 (1.4-3.7) |
Kidney (C64-66, C68) | 9 | 8.9 | 1.0 (0.5-1.9) |
Bladder (C67) | 6 | 13.4 | 0.4 (0.2-1.0) |
Brain and CNS (C70-72) | 4 | 6 | 0.7 (0.2-1.7) |
Thyroid (C73) | 7 | 11.3 | 0.6 (0.2-1.3) |
Hodgkin lymphoma (C81) | 59 | 5 | 11.8 (9.0-15.2) |
Myeloid leukaemia (C92) | 4 | 2.7 | 1.5 (0.4-3.7) |